Is post-transplant metabolic syndrome associated with pre-liver transplant visceral adipose tissue area?

Clin Nutr ESPEN. 2020 Oct:39:61-66. doi: 10.1016/j.clnesp.2020.07.018. Epub 2020 Aug 13.

Abstract

Background: Post-liver transplant metabolic syndrome (PTMS) is a significant independent risk factor for the development of cardiovascular disease. The impact of pre-transplant body composition on the risk of developing PTMS has not been evaluated and was the aim of this study.

Methods: Seventy-five consecutive adult patients listed for liver transplant were included in the analysis. Anthropometric and metabolic data were collected pre-transplant and at three months post-transplant. Metabolic syndrome was defined in accordance with international guidelines. Skeletal muscle area (SMA), visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) areas were derived from computed tomography.

Results: Ten patients (13%) developed de novo PTMS by 3 months post-transplant. Patients who developed PTMS had higher pre-transplant body mass index (BMI) (P = 0.01), VAT (P = 0.001) and SAT (P = 0.008). Univariate logistic regression found that BMI, VAT and SAT were significant predictors for the development of PTMS. After stepwise multivariate analysis, only VAT remained a significant predictor (OR 1.02, 95%CI 1.01-1.04; P = 0.04).

Conclusions: Higher pre-transplant VAT is independently associated with the development of metabolic syndrome three months post-transplant. Body composition analysis using cross-sectional imaging prior to liver transplant can assist with identifying patients at greatest risk for developing PTMS.

Keywords: Liver transplantation; Metabolic syndrome; Visceral adipose tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Humans
  • Intra-Abdominal Fat / diagnostic imaging
  • Liver Transplantation* / adverse effects
  • Metabolic Syndrome* / etiology
  • Risk Factors
  • Subcutaneous Fat / diagnostic imaging